Takeda’s HyQvia® receives expanded market authorization as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP)
March 27, 2025
Takeda Canada
Canada
In Canada, healthcare is a point of pride. And at Takeda, we work every day for better health for people, and a brighter future for the world. We believe that when patients come first, success and impact will always follow. Learn more about us >
Newsroom
Our priorities
Patients
We are unwavering in our commitments to patients at every step.
Learn more
Our medicines
Discover our commitment to deliver a diverse portfolio of innovative treatments.
Learn more
Healthcare professionals
Access information on our products, support for your practice, personalized services, and educational content.
Visit Takeda Connect
Careers
We foster an inclusive environment where employees feel welcomed, empowered, and inspired to use their unique voices and talents.
Join our passionate Canadian team to make a positive impact every day. If you want to make a difference, embrace challenges, and innovate, we invite you to explore career opportunities.
Contact us
Takeda Canada Inc.
- [email protected]
Report an adverse event
Medical information
Report a Product Quality Complaint
Email contact